FGD3 and breast carcinoma: In 2017 Willis et al. analyzed a large cohort of invasive breast cancer patients and compared FGD3 expression with other genes that are used as prognostic factors thanks to their association with cell proliferation like MKI67 [6], PCNA [7] and AURKA [8], regardless of molecular subtype and of ER status.